Hospitals Sue Trump Administration Again Over 340B Drug Discount Program Changes

The American Hospital Association (AHA) has filed another lawsuit against the Trump administration's plan to restructure the 340B federal drug discount program. The proposed changes would shift from upfront medication discounts to after-the-fact rebates, potentially affecting how hospitals provide affordable medications to vulnerable patients. This legal challenge represents ongoing conflict over drug pricing policy and its impact on patient access to essential medications. Hospitals argue the new model could increase costs and burden their ability to serve low-income and uninsured populations.

Originally published on
STAT News
By Tara Bannow
Read full article(opens in new tab)Fetched: October 10, 2026 at 10:00 AM



